Ad is loading...
ANTX
Price
$1.00
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
130 days until earnings call
CSLLY
Price
$88.26
Change
-$3.45 (-3.76%)
Updated
Nov 15 closing price
Ad is loading...

ANTX vs CSLLY

Header iconANTX vs CSLLY Comparison
Open Charts ANTX vs CSLLYBanner chart's image
AN2 Therapeutics
Price$1.00
Change-$0.00 (-0.00%)
Volume$1.25M
CapitalizationN/A
CSL
Price$88.26
Change-$3.45 (-3.76%)
Volume$130.37K
CapitalizationN/A
ANTX vs CSLLY Comparison Chart
Loading...
ANTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CSLLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ANTX vs. CSLLY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTX is a Sell and CSLLY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ANTX: $1.00 vs. CSLLY: $88.26)
Brand notoriety: ANTX and CSLLY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANTX: 459% vs. CSLLY: 512%
Market capitalization -- ANTX: $29.84M vs. CSLLY: $87.08B
ANTX [@Biotechnology] is valued at $29.84M. CSLLY’s [@Biotechnology] market capitalization is $87.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANTX’s FA Score shows that 1 FA rating(s) are green whileCSLLY’s FA Score has 1 green FA rating(s).

  • ANTX’s FA Score: 1 green, 4 red.
  • CSLLY’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANTX and CSLLY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANTX’s TA Score shows that 5 TA indicator(s) are bullish while CSLLY’s TA Score has 4 bullish TA indicator(s).

  • ANTX’s TA Score: 5 bullish, 4 bearish.
  • CSLLY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANTX is a better buy in the short-term than CSLLY.

Price Growth

ANTX (@Biotechnology) experienced а -9.09% price change this week, while CSLLY (@Biotechnology) price change was -5.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ANTX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($87.1B) has a higher market cap than ANTX($29.8M). CSLLY YTD gains are higher at: -7.932 vs. ANTX (-95.120). CSLLY has higher annual earnings (EBITDA): 4.73B vs. ANTX (-71.17M). CSLLY has more cash in the bank: 885M vs. ANTX (105M). CSLLY has higher revenues than ANTX: CSLLY (14.7B) vs ANTX (0).
ANTXCSLLYANTX / CSLLY
Capitalization29.8M87.1B0%
EBITDA-71.17M4.73B-2%
Gain YTD-95.120-7.9321,199%
P/E RatioN/A32.39-
Revenue014.7B-
Total Cash105M885M12%
Total DebtN/A12.2B-
FUNDAMENTALS RATINGS
CSLLY: Fundamental Ratings
CSLLY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANTXCSLLY
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
58%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
57%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 13 days ago
56%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 3 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
61%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
52%
View a ticker or compare two or three
Ad is loading...
ANTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CSLLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYPAX52.21-0.07
-0.13%
Rydex Transportation H
VEUVX32.40-0.13
-0.40%
JPMorgan Europe Dynamic R6
USWGX31.58-0.33
-1.03%
Victory Sustainable World A
EACPX59.45-1.21
-1.99%
Eaton Vance Tax-Managed Multi-Cap Gr A
OPTIX100.43-2.14
-2.09%
Invesco Capital Appreciation R6

ANTX and

Correlation & Price change

A.I.dvisor tells us that ANTX and NKTX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANTX and NKTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
N/A
NKTX - ANTX
26%
Poorly correlated
-6.30%
CSLLY - ANTX
26%
Poorly correlated
-3.76%
RANI - ANTX
25%
Poorly correlated
-3.40%
CERO - ANTX
24%
Poorly correlated
+52.40%
SCPX - ANTX
24%
Poorly correlated
-8.61%
More